Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Sören Nygren | M | - |
Cellda AB
Cellda AB Packaged SoftwareTechnology Services Cellda AB is a Swedish company founded in 2018 by Sören Nygren and Erik Wilander. The company is based in Uppsala, Sweden. Cellda® is a digital pathology company that aims to improve the accuracy and reproducibility of prostate cancer diagnosis. Cellda® provides automatic analysis of digital images of prostate biopsies to distinguish between normal and abnormal samples. The company's goal is to make the diagnosis of prostate cancer faster, more cost-effective, objective, and reproducible with the help of computerized image analysis of scanned microscope images from prostate samples. Accurate histological diagnosis of prostatic adenocarcinoma is an important issue worldwide, as it is the second most frequent malignancy after lung cancer in men worldwide, causing about 360,000 deaths. The CEO is Susanne Bredenberg. | - |
Pia Engholm | F | 54 |
Aprovix AB
Aprovix AB Medical SpecialtiesHealth Technology Aprovix AB develops, manufactures and supplies a device for early detection of pre-stages of cervix cancer. The company was founded by Erik Wilander in 2001 and is headquartered in Uppsala, Sweden. | - |
Jack Spira | M | 71 |
Cellda AB
Cellda AB Packaged SoftwareTechnology Services Cellda AB is a Swedish company founded in 2018 by Sören Nygren and Erik Wilander. The company is based in Uppsala, Sweden. Cellda® is a digital pathology company that aims to improve the accuracy and reproducibility of prostate cancer diagnosis. Cellda® provides automatic analysis of digital images of prostate biopsies to distinguish between normal and abnormal samples. The company's goal is to make the diagnosis of prostate cancer faster, more cost-effective, objective, and reproducible with the help of computerized image analysis of scanned microscope images from prostate samples. Accurate histological diagnosis of prostatic adenocarcinoma is an important issue worldwide, as it is the second most frequent malignancy after lung cancer in men worldwide, causing about 360,000 deaths. The CEO is Susanne Bredenberg. | - |
Sven Olof Mattsson | M | 63 |
Aprovix AB
Aprovix AB Medical SpecialtiesHealth Technology Aprovix AB develops, manufactures and supplies a device for early detection of pre-stages of cervix cancer. The company was founded by Erik Wilander in 2001 and is headquartered in Uppsala, Sweden. | - |
Elisabet Tengqvist | F | - |
Aprovix AB
Aprovix AB Medical SpecialtiesHealth Technology Aprovix AB develops, manufactures and supplies a device for early detection of pre-stages of cervix cancer. The company was founded by Erik Wilander in 2001 and is headquartered in Uppsala, Sweden. | - |
Alexandra de Wever Treschow | M | - |
Aprovix AB
Aprovix AB Medical SpecialtiesHealth Technology Aprovix AB develops, manufactures and supplies a device for early detection of pre-stages of cervix cancer. The company was founded by Erik Wilander in 2001 and is headquartered in Uppsala, Sweden. | 5 años |
Susanne Bredenberg | F | - |
Cellda AB
Cellda AB Packaged SoftwareTechnology Services Cellda AB is a Swedish company founded in 2018 by Sören Nygren and Erik Wilander. The company is based in Uppsala, Sweden. Cellda® is a digital pathology company that aims to improve the accuracy and reproducibility of prostate cancer diagnosis. Cellda® provides automatic analysis of digital images of prostate biopsies to distinguish between normal and abnormal samples. The company's goal is to make the diagnosis of prostate cancer faster, more cost-effective, objective, and reproducible with the help of computerized image analysis of scanned microscope images from prostate samples. Accurate histological diagnosis of prostatic adenocarcinoma is an important issue worldwide, as it is the second most frequent malignancy after lung cancer in men worldwide, causing about 360,000 deaths. The CEO is Susanne Bredenberg. | - |
Erik Forsberg | M | - |
Cellda AB
Cellda AB Packaged SoftwareTechnology Services Cellda AB is a Swedish company founded in 2018 by Sören Nygren and Erik Wilander. The company is based in Uppsala, Sweden. Cellda® is a digital pathology company that aims to improve the accuracy and reproducibility of prostate cancer diagnosis. Cellda® provides automatic analysis of digital images of prostate biopsies to distinguish between normal and abnormal samples. The company's goal is to make the diagnosis of prostate cancer faster, more cost-effective, objective, and reproducible with the help of computerized image analysis of scanned microscope images from prostate samples. Accurate histological diagnosis of prostatic adenocarcinoma is an important issue worldwide, as it is the second most frequent malignancy after lung cancer in men worldwide, causing about 360,000 deaths. The CEO is Susanne Bredenberg. | - |
Tobias Nordin | M | - |
Cellda AB
Cellda AB Packaged SoftwareTechnology Services Cellda AB is a Swedish company founded in 2018 by Sören Nygren and Erik Wilander. The company is based in Uppsala, Sweden. Cellda® is a digital pathology company that aims to improve the accuracy and reproducibility of prostate cancer diagnosis. Cellda® provides automatic analysis of digital images of prostate biopsies to distinguish between normal and abnormal samples. The company's goal is to make the diagnosis of prostate cancer faster, more cost-effective, objective, and reproducible with the help of computerized image analysis of scanned microscope images from prostate samples. Accurate histological diagnosis of prostatic adenocarcinoma is an important issue worldwide, as it is the second most frequent malignancy after lung cancer in men worldwide, causing about 360,000 deaths. The CEO is Susanne Bredenberg. | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Bengt Falk | M | 75 |
Aprovix AB
Aprovix AB Medical SpecialtiesHealth Technology Aprovix AB develops, manufactures and supplies a device for early detection of pre-stages of cervix cancer. The company was founded by Erik Wilander in 2001 and is headquartered in Uppsala, Sweden. | 9 años |
Leena Katriina Niemisto | M | 61 |
Aprovix AB
Aprovix AB Medical SpecialtiesHealth Technology Aprovix AB develops, manufactures and supplies a device for early detection of pre-stages of cervix cancer. The company was founded by Erik Wilander in 2001 and is headquartered in Uppsala, Sweden. | 3 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Suecia | 11 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Erik Wilander
- Red Personal